Retrospective Study
Copyright ©The Author(s) 2020.
World J Clin Cases. Sep 26, 2020; 8(18): 4034-4042
Published online Sep 26, 2020. doi: 10.12998/wjcc.v8.i18.4034
Table 1 Characteristic of the total patient cohort with differences between acute kidney injury and non-acute kidney injury patients within first 7 d after liver transplantation
CharacteristicsAll (n = 205)AKI (n = 93)non-AKI (n = 112)P value
Male/female, n (%)151 (73.7)/54 (26.3)72 (77.4)/21 (22.6)79 (70.5)/33 (77.4)0.265
Age, yr57 ± 1056.51 ± 8.8356.87 ± 11.380.803
BMI, kg/m226.26 ± 4.4627.51 ± 4.9325.22 ± 3.76< 0.001
Etiology of liver disease1
Alcohol-related, n (%)108 (52.7)54 (58.1)54 (48.2)0.16
Viral diseases, n (%)
Hepatitis C, n (%)31 (15.1)15 (16.1)16 (14.3)0.714
Hepatitis B, n (%)17 (18.3)5 (5.4)12 (10.7)0.168
Autoimmune diseases n (%)19 (19.3)7 (7.5)12 (10.7)0.433
Other liver disease n (%)33 (16.1)14 (15.1)19 (17)0.711
Co-morbidites, n (%)
Tumors, n (%)74 (36.1)27 (29)47 (42)0.055
Arterial hypertension, n (%)57 (27.8)24 (25.8)33 (29.5)0.561
CKD, n (%)21 (10.2)7 (7.5)14 (12.5)0.242
T2D, n (%)58 (28.3)27 (29)31 (27.7)0.83
Laboratory values preLT, mean ± SD
Hb (g/L)114.26 ± 22.84110.76 ± 22.6117.17 ± 22.720.045
Bilirubin, µmol/L40 (23-103)48.5 (26.8-112.5)33.5(21.3-88.5)0.075
Creatinine, µmol/L98.28 ± 75.0596.16 ± 64.08100.04 ± 83.310.714
INR1.61 ± 0.561.68 ± 0.561.55 ± 0.550.115
Na, mmol/L135.3 ± 4.87134.78 ± 5.27135.73 ± 4.480.18
eGFR, mL/min/1.73 m²90.61 ± 47.2790.64 ± 51.5990.58 ± 43.590.993
MELD16.94 ± 7.5817.66 ± 7.216.35 ± 7.860.22
MELD-Na19.39 ± 7.7620.45 ± 7.3218.49 ± 8.040.08
Intraoperative parameters
FFP, mL2112.19 ± 1393.222388.4 ± 1389.41873.2 ± 1358.20.01
Cristalloids, mL5020.67 ± 1506.974941.54 ± 1281.15090.58 ± 1684.740.493
Colloids, mL1724.77 ± 925.121891.76 ± 913.241578.65 ± 914.90.018
Albumins, mL741.79 ± 378.36823.08 ± 404.65670.67 ± 340.020.005
CIT, h437.67 ± 135.74452.3 ± 136.26427.42 ± 135.310.304
WIT, min27.29 ± 6.9328 ± 7.7226.59 ± 6.130.425
RBCs, L5.7 (3.7-8.2)6 (4.9-9.9)4.71 (3-7.5)0.001